FTXH
First Trust Nasdaq Pharmaceuticals ETF [FTXH] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
FTXH Stock Summary
Top 10 Correlated ETFs
FTXH
Top 10 Correlated Stocks
FTXH
In the News
FTXH Financial details
Company Rating
-
Market Cap
20.56M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.1
Dividend %
1.51%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
1.4%
SMA50
-2.55%
SMA100
-5.3%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
23.85-28.41
52W High
-0.04%
52W Low
+21.7%
RSI
58.65
Rel Volume
0.08
Avg Volume
5.87K
Volume
475
Perf Week
2.87%
Perf Month
2.75%
Perf Quarter
-5.18%
Perf Half Y
-4.47%
-
-
-
-
Beta
0.56
-
-
Volatility
0.26%, 0.34%
Prev Close
0.43%
Price
27.99
Change
1.12%
FTXH Financial Performance
FTXH Frequently Asked Questions
What is First Trust Nasdaq Pharmaceuticals ETF stock symbol ?
First Trust Nasdaq Pharmaceuticals ETF is a US stock and trading under the symbol FTXH
What is First Trust Nasdaq Pharmaceuticals ETF stock quote today ?
First Trust Nasdaq Pharmaceuticals ETF stock price is $27.99 today.
Is First Trust Nasdaq Pharmaceuticals ETF stock public?
Yes, First Trust Nasdaq Pharmaceuticals ETF is a publicly traded company.
Company Profile
- Volume Average 5.87K
- Market Capitalization 20.56M
- Headquarters US
- IPO Date 2016-09-22
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.
